Antimicrobial resistance (AMR) is a growing global health concern. It threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses, and fungi. One key strategy to combat this crisis is the implementation of Antimicrobial Stewardship Programs (ASPs) in hospital settings.
ASPs are coordinated interventions designed to improve and measure the appropriate use of antimicrobials by promoting the selection of the optimal antimicrobial drug regimen, dose, duration of therapy, and route of administration. They aim to achieve optimal clinical outcomes related to antimicrobial use, minimize toxicity and other adverse events, reduce the costs of health care for infections, and limit the selection for antimicrobial resistant strains.
Successful ASPs typically involve a multidisciplinary team including infectious disease physicians, pharmacists, clinical microbiologists, and infection preventionists. They leverage hospital informatics systems for surveillance and reporting of antimicrobial usage and resistance patterns, provide regular feedback to prescribers, and offer education and guidelines on optimal antimicrobial use. The use of rapid diagnostic technologies can also enhance the effectiveness of ASPs by enabling more timely and targeted antimicrobial use.
Multiple studies have shown that ASPs can significantly improve patient outcomes. They can reduce the incidence of antimicrobial resistance, Clostridium difficile infection, and other healthcare-associated infections, decrease patient length of stay, and even reduce mortality in some settings. Furthermore, they can lead to substantial cost savings for hospitals.
Given the increasing threat of AMR, the role of antimicrobial stewardship in optimizing patient care in hospital settings is more crucial than ever. It requires a concerted, multidisciplinary effort, but the potential benefits in terms of improved patient outcomes and cost savings are substantial. As healthcare professionals, we must advocate for and support the implementation and ongoing development of ASPs in our institutions.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation